Published in Parasite Immunol on February 01, 2013
Immunoregulation in human American leishmaniasis: balancing pathology and protection. Parasite Immunol (2014) 0.90
The Role of Nitric Oxide and Reactive Oxygen Species in the Killing of Leishmania braziliensis by Monocytes from Patients with Cutaneous Leishmaniasis. PLoS One (2016) 0.86
NK cell activity differs between patients with localized and diffuse cutaneous leishmaniasis infected with Leishmania mexicana: a comparative study of TLRs and cytokines. PLoS One (2014) 0.82
A Defective Oxidative Burst and Impaired Antigen Presentation are Hallmarks of Human Visceral Leishmaniasis. J Clin Immunol (2014) 0.80
Functional activity of monocytes and macrophages in HTLV-1 infected subjects. PLoS Negl Trop Dis (2014) 0.78
Clinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine Antimoniate. PLoS Negl Trop Dis (2016) 0.76
Leishmania infantum and Leishmania braziliensis: Differences and Similarities to Evade the Innate Immune System. Front Immunol (2016) 0.75
Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol (2011) 2.93
Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect Immun (2002) 2.90
Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect Immun (2005) 2.29
Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis (2010) 2.24
Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. Nat Rev Immunol (2006) 2.24
B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity (2004) 2.21
Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J Immunol (2006) 1.94
Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis. Immunol Lett (2005) 1.94
TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell development and the resolution of lesions. J Immunol (2009) 1.91
Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis. Infect Immun (2001) 1.90
Malaria primes the innate immune response due to interferon-gamma induced enhancement of toll-like receptor expression and function. Proc Natl Acad Sci U S A (2009) 1.70
NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J Exp Med (2007) 1.57
TLR9 is required for protective innate immunity in Gram-negative bacterial pneumonia: role of dendritic cells. J Immunol (2007) 1.49
TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis. Eur J Immunol (2007) 1.46
Recruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis. Parasite Immunol (2009) 1.43
Distinct responses of monocytes to Toll-like receptor ligands and inflammatory cytokines. Int Immunol (2004) 1.31
Toll-like receptors and leishmaniasis. Infect Immun (2007) 1.27
T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy. Clin Diagn Lab Immunol (2002) 1.26
Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis. Parasite Immunol (2007) 1.25
Mucosal leishmaniasis patients display an activated inflammatory T-cell phenotype associated with a nonbalanced monocyte population. Scand J Immunol (2006) 1.24
Antigen specific correlations of cellular immune responses in human leishmaniasis suggests mechanisms for immunoregulation. Clin Exp Immunol (2004) 1.22
Differential role for CD80 and CD86 in the regulation of the innate immune response in murine polymicrobial sepsis. PLoS One (2009) 1.17
TAP-1 indirectly regulates CD4+ T cell priming in Toxoplasma gondii infection by controlling NK cell IFN-gamma production. J Exp Med (2007) 1.17
Disparate immunoregulatory potentials for double-negative (CD4- CD8-) alpha beta and gamma delta T cells from human patients with cutaneous leishmaniasis. Infect Immun (2006) 1.15
Different cell surface oligomeric states of B7-1 and B7-2: implications for signaling. Proc Natl Acad Sci U S A (2005) 1.15
Blockade of CD86 ameliorates Leishmania major infection by down-regulating the Th2 response. J Infect Dis (1996) 1.14
CD86 regulates IgG1 production via a CD19-dependent mechanism. J Immunol (2007) 1.03
Lesion size correlates with Leishmania antigen-stimulated TNF-levels in human cutaneous leishmaniasis. Am J Trop Med Hyg (2011) 1.01
Lymph node hypertrophy following Leishmania major infection is dependent on TLR9. J Immunol (2011) 1.00
Characterization of the immune response to Leishmania infantum recombinant antigens. Microbes Infect (2003) 0.97
Immunoregulatory mechanisms and CD4-CD8- (double negative) T cell subpopulations in human cutaneous leishmaniasis: a balancing act between protection and pathology. Int Immunopharmacol (2008) 0.95
CD16+ monocytes in human cutaneous leishmaniasis: increased ex vivo levels and correlation with clinical data. J Leukoc Biol (2005) 0.95
CD40 signaling synergizes with TLR-2 in the BCR independent activation of resting B cells. PLoS One (2011) 0.95
Why does immunity to parasites take so long to develop? Nat Rev Immunol (2010) 0.92
The expression of TLR9 in human cutaneous leishmaniasis is associated with granuloma. Parasite Immunol (2010) 0.90
Dendritic cells matured by inflammation induce CD86-dependent priming of naive CD8+ T cells in the absence of their cognate peptide antigen. J Immunol (2009) 0.89
CD4(+) T cells defined by their Vβ T cell receptor expression are associated with immunoregulatory profiles and lesion size in human leishmaniasis. Clin Exp Immunol (2011) 0.89
Monocyte cytokine and costimulatory molecule expression in patients infected with Leishmania mexicana. Parasite Immunol (2007) 0.84
Role of costimulatory molecules in immune response of patients with cutaneous leishmaniasis. Microbes Infect (2004) 0.82
The expression of TLR2, TLR4 and TLR9 in the epidermis of patients with cutaneous leishmaniasis. J Dermatol Sci (2010) 0.78
Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J Clin Invest (1985) 3.41
New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis (1986) 2.92
Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection. Infect Immun (1981) 2.88
Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells. Science (1995) 2.74
Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. N Engl J Med (1990) 2.67
An endogenous retrovirus mediating deletion of alpha beta T cells? Nature (1991) 2.57
Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. J Infect Dis (1996) 2.42
A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis (1986) 2.24
Cell mediated immunity in American cutaneous and mucosal leishmaniasis. J Immunol (1985) 2.24
Cytokine profile and pathology in human leishmaniasis. Braz J Med Biol Res (1998) 1.99
Selection of a skin test antigen for American visceral leishmaniasis. Am J Trop Med Hyg (1986) 1.93
Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis. Infect Immun (2001) 1.90
A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12. J Exp Med (1995) 1.81
Multiclonal Leishmania braziliensis population structure and its clinical implication in a region of endemicity for American tegumentary leishmaniasis. Infect Immun (2004) 1.72
Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg (1991) 1.71
Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony. Am J Trop Med Hyg (2001) 1.65
Atypical manifestations of tegumentary leishmaniasis in a transmission area of Leishmania braziliensis in the state of Bahia, Brazil. Trans R Soc Trop Med Hyg (2009) 1.63
Down-regulation of Th1 type of response in early human American cutaneous leishmaniasis. J Infect Dis (1999) 1.53
Enhanced helminthotoxic capacity of eosinophils from patients with eosinophilia. N Engl J Med (1980) 1.50
Inverse association between skin response to aeroallergens and Schistosoma mansoni infection. Int Arch Allergy Immunol (2000) 1.49
Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases. J Trop Med Hyg (1986) 1.48
IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis. Cytokine (2000) 1.47
Recruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis. Parasite Immunol (2009) 1.43
Leishmania donovani: an opportunistic microbe associated with progressive disease in three immunocompromised patients. Lancet (1986) 1.42
Circulating immune complexes and rheumatoid factor in schistosomiasis and visceral leishmaniasis. Am J Trop Med Hyg (1983) 1.38
Immunofluorescent antibody test in American visceral leishmaniasis: sensitivity and specificity of different morphological forms of two Leishmania species. Am J Trop Med Hyg (1983) 1.32
Tumor necrosis factor (cachectin) in human visceral leishmaniasis. J Infect Dis (1991) 1.29
Interleukin-12 restores interferon-gamma production and cytotoxic responses in visceral leishmaniasis. J Infect Dis (1996) 1.29
Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis. Parasite Immunol (2007) 1.25
HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunol (2001) 1.25
Mucosal leishmaniasis patients display an activated inflammatory T-cell phenotype associated with a nonbalanced monocyte population. Scand J Immunol (2006) 1.24
Lymphadenopathy as the first sign of human cutaneous infection by Leishmania braziliensis. Am J Trop Med Hyg (1995) 1.24
Antigen specific correlations of cellular immune responses in human leishmaniasis suggests mechanisms for immunoregulation. Clin Exp Immunol (2004) 1.22
Immune responses of leishmaniasis patients to heat shock proteins of Leishmania species and humans. Infect Immun (1995) 1.20
Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralis. J Infect Dis (1998) 1.17
Evidence of a T helper type 2 activation in human schistosomiasis. Eur J Immunol (1996) 1.16
Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/C mice. Am J Trop Med Hyg (1996) 1.16
Cytotoxicity in human mucosal and cutaneous leishmaniasis. Parasite Immunol (1995) 1.15
Human T cell responses to gp63, a surface antigen of Leishmania. J Immunol (1991) 1.12
Human immune responses to Schistosoma mansoni vaccine candidate antigens. Infect Immun (2000) 1.12
Polar and subpolar diffuse cutaneous leishmaniasis in Brazil: clinical and immunopathologic aspects. Int J Dermatol (1995) 1.10
Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis. J Immunol (1991) 1.09
Characterization of a membrane antigen of Leishmania amazonensis that stimulates human immune responses. J Immunol (1991) 1.09
Variation of cytokine patterns related to therapeutic response in diffuse cutaneous leishmaniasis. Exp Parasitol (1996) 1.08
IL-17 and Regulatory Cytokines (IL-10 and IL-27) in L. braziliensis Infection. Parasite Immunol (2011) 1.07
Transforming growth factor-beta in human cutaneous leishmaniasis. Am J Pathol (1995) 1.05
Phenotypic and functional characteristics of CD28+ and CD28- cells from chagasic patients: distinct repertoire and cytokine expression. Clin Exp Immunol (2004) 1.04
Cytokine mRNA profile of peripheral blood mononuclear cells isolated from individuals with Trypanosoma cruzi chronic infection. Scand J Immunol (1997) 1.04
Bacterial infections in patients with visceral leishmaniasis. J Infect Dis (1990) 1.03
Recombinant leishmania antigens for serodiagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol (2005) 1.03
Evaluation of cefamandole therapy of patients with bacterial meningitis. J Infect Dis (1978) 1.03
Schistosoma mansoni antigens modulate the allergic response in a murine model of ovalbumin-induced airway inflammation. Clin Exp Immunol (2010) 1.02
Conditions required for Fc-dependent immune complex enhancement of antigen-specific lymphocyte blastogenesis. J Immunol (1980) 1.02
High HTLV-1 proviral load, a marker for HTLV-1 associated myelopathy/tropical spastic paraparesis, is also detected in patients with infective dermatitis associated with HTLV-1. Braz J Med Biol Res (2009) 1.00
Suppression of lymphocyte proliferative responses by sera from patients with American visceral leishmaniasis. Am J Trop Med Hyg (1986) 0.99
Immunochemotherapy in American cutaneous leishmaniasis: immunological aspects before and after treatment. Mem Inst Oswaldo Cruz (2001) 0.99
Mapping human T cell epitopes in leishmania gp63. Identification of cross-reactive and species-specific epitopes. J Immunol (1993) 0.99
Role of transforming growth factor-beta in the preferential induction of T helper cells of type 1 by staphylococcal enterotoxin B. Eur J Immunol (1993) 0.98
Asymptomatic Leishmania chagasi infection in relatives and neighbors of patients with visceral leishmaniasis. Mem Inst Oswaldo Cruz (1998) 0.98
PCR amplification of the mitochondrial DNA minisatellite region to detect Schistosoma mansoni infection in Biomphalaria glabrata snails. J Parasitol (1997) 0.97
Lymphocyte reactivity to mitogens in American visceral leishmaniasis. Braz J Med Biol Res (1983) 0.97
[Outbreak of American cutaneous leishmaniasis in Canoa, Santo Amaro, Bahia, Brazil]. Rev Soc Bras Med Trop (2000) 0.97
In vitro responses to Leishmania antigens by lymphocytes from patients with leishmaniasis or Chagas' disease. J Clin Invest (1990) 0.96
Isolation of Leishmania mexicana amazonensis from the bone marrow in a case of American visceral leishmaniasis. Am J Trop Med Hyg (1986) 0.96
Influence of human T-cell lymphocytotropic virus type 1 infection on serologic and skin tests for strongyloidiasis. Am J Trop Med Hyg (2001) 0.96
Leishmaniasis recidiva cutis in American cutaneous leishmaniasis. Int J Dermatol (1993) 0.95
Lymphadenopathy associated with Leishmania braziliensis cutaneous infection. Am J Trop Med Hyg (1992) 0.95
Morbidity associated with Schistosoma mansoni infection determined by ultrasound in an endemic area of Brazil, Caatinga do Moura. Am J Trop Med Hyg (2001) 0.94
Diminished in vitro production of interleukin-1 and tumor necrosis factor-alpha during acute visceral leishmaniasis and recovery after therapy. J Infect Dis (1992) 0.94
Effect of LACK and KMP11 on IFN-gamma production by peripheral blood mononuclear cells from cutaneous and mucosal leishmaniasis patients. Scand J Immunol (2005) 0.94
Serum markers of rheumatoid arthritis in visceral leishmaniasis: rheumatoid factor and anti-cyclic citrullinated peptide antibody. J Autoimmun (2007) 0.94
Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state. Clin Exp Immunol (2006) 0.93
Modulation of eosinophil cytotoxicity by blood mononuclear cells from healthy subjects and patients with chronic schistosomiasis mansoni. Cell Immunol (1984) 0.93
Basidiobolomycosis: a case report. Pediatr Dermatol (1991) 0.93
Interleukin-6 expression and gene polymorphism are associated with severity of periodontal disease in a sample of Brazilian individuals. Clin Exp Immunol (2007) 0.92
Immunoglobulin E and systemic lupus erythematosus. Braz J Med Biol Res (2004) 0.92
Correlation between cell-mediated immunity and degree of infection in subjects living in an endemic area of schistosomiasis. Eur J Immunol (1993) 0.91
FLI1 polymorphism affects susceptibility to cutaneous leishmaniasis in Brazil. Genes Immun (2011) 0.91
Immunoregulatory networks in human Chagas disease. Parasite Immunol (2014) 0.90
Immunoregulation in human American leishmaniasis: balancing pathology and protection. Parasite Immunol (2014) 0.90
The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.90
Prevalence of human T-cell lymphotropic virus type 1 infection in hospitalized patients with tuberculosis. Int J Tuberc Lung Dis (2009) 0.89
T-cell repertoire analysis in acute and chronic human Chagas' disease: differential frequencies of Vbeta5 expressing T cells. Scand J Immunol (2000) 0.89